loading
Schlusskurs vom Vortag:
$4.29
Offen:
$4.2
24-Stunden-Volumen:
147.74K
Relative Volume:
0.08
Marktkapitalisierung:
$11.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.7639
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
+1.23%
1M Leistung:
+427.60%
6M Leistung:
+70.95%
1J Leistung:
+71.25%
1-Tages-Spanne:
Value
$3.90
$4.35
1-Wochen-Bereich:
Value
$3.82
$4.35
52-Wochen-Spanne:
Value
$0.64
$4.45

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name
Firmenname
Lixte Biotechnology Holdings Inc
Name
Telefon
310 203 2902
Name
Adresse
248 ROUTE 25A, EAST SETAUKET
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
LIXT's Discussions on Twitter

Vergleichen Sie LIXT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LIXT
Lixte Biotechnology Holdings Inc
4.11 12.99M 0 -4.69M -3.81M -2.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten

pulisher
Jul 25, 2025

Lixte Biotechnology Holdings Inc. Equity Warrant Stock Analysis and ForecastExceptional portfolio growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Does Lixte Biotechnology Holdings Inc. stock pay reliable dividendsFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Lixte Biotechnology Holdings Inc. Equity Warrant stock priceConsistent triple-digit returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionMarket Trend Watch - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Lixte Biotechnology Holdings Inc. stockFree Trading Strategy Suggestions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 22, 2025

What analysts say about Lixte Biotechnology Holdings Inc. Equity Warrant stockHigh-octane gains - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Lixte Biotechnology Holdings Inc. Equity Warrant a good long term investmentFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Lixte Biotechnology Holdings Inc. stock priceFree Technical Analysis Support - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

LIXT adds 2 directors after Series B deal; CMO resigns, board reshuffle | LIXTW SEC FilingForm 8-K - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Lixte Biotechnology Holdings Inc. Stock Analysis and ForecastStrongest growth potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

Is Lixte Biotechnology Holdings Inc. a good long term investmentAccelerated investment success - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 22:24:49 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

LIXTE Biotechnology regains Nasdaq compliance - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Lixte Biotechnology shares fall 2.38% premarket after regaining Nasdaq compliance. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Fluence Energy's Price Target Raised by Barclays: A Shift in Market Dynamics? - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

LIXTE Biotechnology Regains Nasdaq Listing Compliance with $5 Million Financing - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Lixte Biotechnology Holdings Inc. stock outlookRapid Gain Targets - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Lixte Biotechnology Regains Nasdaq Compliance After Fundraising - The Globe and Mail

Jul 17, 2025
pulisher
Jul 17, 2025

Lixte Biotechnology shares fall 3.23% premarket after closing a $5 million private placement. - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology Regains Nasdaq Compliance with $5M Financing - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyFree Consultation - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology Meets Nasdaq Listing Requirement, Shares Down - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology's Compliance Win: A Turning Point for Clinical Gains and Stock Stability? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital Raise - Nasdaq

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology regains Nasdaq compliance after $5M funding. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Biotechnology Holdings Regains Nasdaq Listing Compliance with New Financing - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

LIXTE Secures $6.5M Funding, Maintains Nasdaq Listing While Advancing Cancer Drug Trials - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

How Lixte Biotechnology Holdings Inc. Equity Warrant stock performs during market volatility - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Lixte Biotechnology Holdings Inc. stock price move sharplyFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lixte Biotechnology Holdings Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025

Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):